Cargando…
Early Improvement and Marriage Are Determinants of the 12-Month Treatment Outcome of Paroxetine in Outpatients with Panic Disorder
OBJECTIVE: In this study, we investigated the determinants of remission and discontinuation of paroxetine pharmacotherapy in outpatients with panic disorder (PD). METHODS: Subjects were 79 outpatients diagnosed with PD who took 10–40 mg/day of paroxetine for 12 months. The candidate therapeutic dete...
Autores principales: | Watanabe, Takashi, Ueda, Mikito, Ishiguro, Shin, Hayashi, Yuki, Aoki, Akiko, Shinozaki, Masataka, Kato, Kazuko, Akiyama, Kazufumi, Shimoda, Kazutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678480/ https://www.ncbi.nlm.nih.gov/pubmed/29073750 http://dx.doi.org/10.9758/cpn.2017.15.4.382 |
Ejemplares similares
-
Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
por: Aoki, Akiko, et al.
Publicado: (2014) -
Genetic Polymorphism of 1019C/G (rs6295) Promoter of Serotonin 1A Receptor and Catechol-O-Methyltransferase in Panic Disorder
por: Watanabe, Takashi, et al.
Publicado: (2017) -
PS213. Pharmacokinetics of mirtazapine and its hydroxylated metabolite in Japanese psychiatric patients treated with mirtazapine
por: Watanabe, Takashi, et al.
Publicado: (2016) -
Efficacy of atropine combined with paroxetine in vagus nerve excitatory panic disorder
por: Du, Na, et al.
Publicado: (2015) -
Three year naturalistic outcome study of panic disorder patients treated with paroxetine
por: Dannon, Pinhas N, et al.
Publicado: (2004)